Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study

Journal of the Indian Medical Association

Volumn 103, Issue 12, 2005, Pages 708-709

  Walwaikar, Pradeep P ^a   Kulkarni, Sujay S ^a   Bargaje, Rahul S ^a  

^a JB Chemicals and Pharmaceuticals Limited   (India)

Author keywords

Itopride; Non ulcer dyspepsia; Prokinetic; Safety

Indexed keywords

ARTICLE; BLINDNESS; CANCER; CARDIOVASCULAR DISEASE; COMMUNITY CARE; DIABETES MELLITUS; DISEASE CONTROL; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; INDIA; INFANT MORTALITY; INFECTION CONTROL; INJURY; IODINE DEFICIENCY; LAW; LEPROSY; MATERNAL MORTALITY; PROPHYLAXIS; RESEARCH; TECHNOLOGY; TUBERCULOSIS;

EID: 33744737243     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Olsson S, Edwards IR - Tachycardia during cisapride treatment. BMJ 1992; 305: 748-9.
2. Kakiuchi M, Saito T - Pharmacological evaluation of itopride hydrochloride with regard to drug induced arrhythmias. Jpn Pharmacol Ther 1997; 25: 811-7.
3. Mushiroda T, Douya R - The involvement of flavin containing mono-oxygenase but not CYP3A4 in the metabolism of itopride hydrochloride: a gastroprokinetic agent-comparison with cisapride and mosapride citrate. Drug Metab Dispos 2000; 28: 1231-7.
4. Kumar RA, Venketakrishnan L - Clinical evaluation of the efficacy and tolerability of itopride hydrochloride in patients with nonulcer dyspepsia or chronic gastritis. Indian J Clin Pract 2003; 13: 2-6.
5. Otsubu T, Mizokami Y - Effect of itopride hydrochloride on non-ulcer dyspepsia. Clin Med 1998; 14: 94-7.